Danshensu protects vascular endothelia in a rat model of hyperhomocysteinemia

Acta Pharmacol Sin. 2010 Oct;31(10):1395-400. doi: 10.1038/aps.2010.167. Epub 2010 Sep 27.

Abstract

Aim: To examine whether danshensu could protect vascular endothelia in a rat model of hyperhomocysteinemia.

Methods: The model was established by feeding rats with a methionine-rich diet (1 g·kg⁻¹·d⁻¹) for 3 months. Immediately following the discontinuation of methionine-rich diet, rats were treated with danshensu (67.5 mg·kg⁻¹·d⁻¹, po) or saline for 3 additional months. One group of rats receiving vitamin mixture (folic acid, vitamin B12 and vitamin B6) was included as a positive control. One group of rats not exposed to methionine-rich diet was also included as a blank control. The expression of tumor necrosis factor-alpha (TNF-alpha) and intercellular adhesion molecule-1 (ICAM-1) protein in the descending aorta was examined using immunohistochemistry and Western blot. Homocysteine and blood concentration of endothelin and nitric oxide (NO) was also examined.

Results: Methionine-rich diet resulted in accumulation of "foam cells", up-regulated expression of TNF-alpha and ICAM-1 in the descending aorta, and significantly increased serum homocysteine. Plasma endothelin concentration was significantly increased; NO was decreased. Danshensu treatment, either simultaneous to methionine-rich diet or afterwards, attenuated the above mentioned changes.

Conclusion: Chronic treatment with danshensu could prevent/attenuate the formation of atherosclerosis. Potential mechanisms include inhibited expression of representative proinflammatory cytokines and adhesion molecules in arterial endothelia. Changes in homocysteine and circulating molecules that control vascular contraction/relaxation via endothelial cells (eg, endothelin and NO) were also implicated.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Aorta, Thoracic / metabolism
  • Atherosclerosis / metabolism
  • Atherosclerosis / prevention & control
  • Cardiovascular Agents / pharmacology*
  • Cardiovascular Agents / therapeutic use
  • Diet
  • Disease Models, Animal
  • Endothelins / blood
  • Endothelium, Vascular / drug effects*
  • Endothelium, Vascular / metabolism
  • Female
  • Hyperhomocysteinemia / drug therapy*
  • Hyperhomocysteinemia / metabolism
  • Hyperhomocysteinemia / pathology
  • Intercellular Adhesion Molecule-1 / blood
  • Lactates / pharmacology*
  • Lactates / therapeutic use
  • Male
  • Methionine
  • Nitric Oxide / blood
  • Rats
  • Rats, Wistar
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Cardiovascular Agents
  • Endothelins
  • Lactates
  • Tumor Necrosis Factor-alpha
  • Intercellular Adhesion Molecule-1
  • Nitric Oxide
  • 3,4-dihydroxyphenyllactic acid
  • Methionine